Cargando…

AURKB as a Promising Prognostic Biomarker in Hepatocellular Carcinoma

The Aurora kinases form a family of 3 genes encoding serine/threonine kinases and are involved in the regulation of cell division during the mitosis. This study was designed to investigate the prognostic role of Aurora kinases in hepatocellular carcinoma (HCC). In this study, we analyzed the express...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Jingchuan, Zhang, Yingai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637395/ https://www.ncbi.nlm.nih.gov/pubmed/34866894 http://dx.doi.org/10.1177/11769343211057589

Ejemplares similares

AURKB: a promising biomarker in clear cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019)

Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma
por: Zhang, Yingai, et al.
Publicado: (2019)

AURKB, CHEK1 and NEK2 as the Potential Target Proteins of Scutellaria barbata on Hepatocellular Carcinoma: An Integrated Bioinformatics Analysis
por: Huang, Chaoyuan, et al.
Publicado: (2021)

AURKB Promotes the Metastasis of Gastric Cancer, Possibly by Inducing EMT
por: Wang, Zhen, et al.
Publicado: (2020)

Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma
por: Rao, Qian‐Wen, et al.
Publicado: (2020)

Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights
por: Yu, James, et al.
Publicado: (2023)

Lipoprotein (a): a promising prognostic biomarker in patients with hepatocellular carcinoma after curative resection
por: Gao, Xing-hui, et al.
Publicado: (2018)

CLEC1B is a Promising Prognostic Biomarker and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Liang, Xiaoliang, et al.
Publicado: (2022)

DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Song, Danjun, et al.
Publicado: (2020)

ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m(6)A-dependent manner
por: Zhang, Xiaolei, et al.
Publicado: (2020)

MYC degradation via AURKB inhibition: a new brake in the path to T-ALL
por: Zhang, Wu, et al.
Publicado: (2020)

AURKB promotes gastric cancer progression via activation of CCND1 expression
por: Nie, Min, et al.
Publicado: (2020)

ZWINT is a Promising Therapeutic Biomarker Associated with the Immune Microenvironment of Hepatocellular Carcinoma
por: Lin, Tong, et al.
Publicado: (2021)

ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma
por: Zhang, Shirong, et al.
Publicado: (2022)

MARCKS is a New Prognostic Biomarker in Hepatocellular Carcinoma
por: Lu, Haoran, et al.
Publicado: (2023)

High expression of FAM13A was associated with increasing the liver cirrhosis risk
por: Zhang, Yingai, et al.
Publicado: (2019)

Haspin inhibition reveals functional differences of interchromatid axis–localized AURKB and AURKC
por: Quartuccio, Suzanne M., et al.
Publicado: (2017)

AURKB Enhances Chromosomal Remodeling of Telomeric Genes and Accelerates Tumorigenesis of Uveal Melanoma
por: Wang, Huixue, et al.
Publicado: (2023)

Multi-omics analysis identifies potential mechanisms of AURKB in mediating poor outcome of lung adenocarcinoma
por: Huang, Jie, et al.
Publicado: (2021)

Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma
por: Huang, Yan-Lin, et al.
Publicado: (2019)

ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma
por: Wang, Zhen-Zhen, et al.
Publicado: (2022)

Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma
por: Zhang, Qifan, et al.
Publicado: (2021)

Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma
por: Liu, Kun, et al.
Publicado: (2016)

INKA2-AS1 Is a Potential Promising Prognostic-Related Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
por: Li, Wenke, et al.
Publicado: (2023)

AURKB activates EMT through PI3K/AKT signaling axis to promote ICC progression
por: Ma, Peng, et al.
Publicado: (2023)

AURKB-mediated effects on chromatin regulate binding versus release of XIST RNA to the inactive chromosome
por: Hall, Lisa L., et al.
Publicado: (2009)

Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma
por: Xie, Hui, et al.
Publicado: (2013)

HI-511 overcomes melanoma drug resistance via targeting AURKB and BRAF V600E
por: Chang, Xiaoyu, et al.
Publicado: (2020)

Potential Molecular Mechanisms of AURKB in the Oncogenesis and Progression of Osteosarcoma Cells: A Label-Free Quantitative Proteomics Analysis
por: Pi, Wen-Sen, et al.
Publicado: (2019)

Amplifications of AURKA and AURKB in a Burkitt lymphoma immunodeficiency-associated type: a case report
por: de Oliveira, Fábio Morato, et al.
Publicado: (2023)

PROZ May Serve as a Prognostic Biomarker for Early Hepatocellular Carcinoma
por: Jiang, Xiaocong, et al.
Publicado: (2021)

Comprehensive analysis of ASB3 as a prognostic biomarker in hepatocellular carcinoma
por: Qin, Zhongqiang, et al.
Publicado: (2023)

Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy
por: Liao, Yuqian, et al.
Publicado: (2018)

Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma
por: Mo, Meile, et al.
Publicado: (2022)

GIV is a promising novel poor prognostic factor in liver hepatocellular carcinoma
por: Zou, Zhenzhen, et al.
Publicado: (2022)

Immunological inflammatory biomarkers as prognostic predictors for advanced hepatocellular carcinoma
por: Nakano, M., et al.
Publicado: (2021)

AURKB, in concert with REST, acts as an oxygen-sensitive epigenetic regulator of the hypoxic induction of MDM2
por: Kim, Iljin, et al.
Publicado: (2022)

Karonudib is a promising anticancer therapy in hepatocellular carcinoma
por: Hua, Xiangwei, et al.
Publicado: (2019)

CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
por: Zhou, Huifang, et al.
Publicado: (2019)

Fidgetin as a potential prognostic biomarker for hepatocellular carcinoma
por: Zhou, Bin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ieamcedhb3n50m830nh4o38i91